BioSpectrum Asia Magazine - March 2024
BioSpectrum Asia Magazine - March 2024
Go Unlimited with Magzter GOLD
Read BioSpectrum Asia along with 8,500+ other magazines & newspapers with just one subscription View catalog
1 Month $9.99
1 Year$99.99
$8/month
Subscribe only to BioSpectrum Asia
1 Year $10.99
Save 7%
Buy this issue $0.99
In this issue
ENGENDERING INCLUSIVITY & DIVERSITY IN LIFE SCIENCES
We are celebrating International Women's Day this time around by spotlighting women's roles and challenges in life sciences, spanning leadership, clinical trials participation and pay parity issues. Section I of the story highlights remarkable women leading public sector organisations in life sciences in APAC. Section II discusses the persistent issue of pay parity in the sector, while the final section tackles issues related to women in clinical trials. Let's delve deeper.
Korea designs sweat resistant wearable robot sensor
New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.
1 min
Why Singapore is Deep Tech Innovation Frontrunner
Move over Artificial Intelligence Al) and Machine Learning ML), there's a new technology on the block Deep Tech. This latest technology holds immense potential for the life sciences industry, and Singapore is leaving no stone unturned in becoming a deep tech hub. From strategic investments to collaborative initiatives and a supportive regulatory environment, read on to find out about the country's initiatives in becoming a deep tech superpower.
4 mins
Can Shorter Regimens Eliminate Drug-Resistant Tuberculosis?
The World Health Organization (WHO) has taken a significant stride in the battle against Tuberculosis (TB) by introducing shorter drug regimens, aiming to curb a disease that claims countless lives globally. This innovative approach addresses the urgent need for more efficient treatments, especially in regions where TB's toll is highest. With traditional therapies often posing risks to liver health, these shortened regimens offer hope, minimising such concerns while enhancing treatment adherence.
5 mins
How pharma is finally researching issues that primarily affect women
Pharma is now concentrating on problems that impact women. Female participation will now directly contribute to cures for diseases that affect them, since more studies specifically targeted at women are planned.
8 mins
Championing PAY PARITY
Despite women's significant strides and contributions in the healthcare field, they are paid less than men. Unfortunately, as is the case in most spheres, persistent pay disparities plague the life sciences sector. How big is the gender pay gap in the pharma industry? Are companies and the industry doing enough to address this issue? Let's find out.
6 mins
ENGENDERING INCLUSIVITY & DIVERSITY IN LIFE SCIENCES
Globally, women constitute 46 per cent of the workforce in the public sector, whereas in the private sector, they represent 33 per cent. The public sector maintains a higher representation of women as employees compared to the private sector as per data from the World Bank.
10+ mins
US FDA approves first medication to treat severe frostbite
The US Food and Drug Administration (FDA) has approved Eicos Sciences Inc’s Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.
1 min
Japanese startup RevolKa to create highly functional proteins by using AI-driven platform
RevolKa, a venture-backed biotech startup providing a gamechanging protein engineering technology platform, based in Japan, has signed a contract research agreement with Sekisui Chemical.
1 min
Taiwan's Anbogen secures $12.5M for advancing precision oncology drug development
Taiwan-based startup Anbogen Therapeutics, a clinical-stage biotechnology company specialising in groundbreaking cancer drug development, has announced the successful completion of its Series A funding round.
1 min
Samsung Biologics & LegoChem Biosciences team up for ADC development
South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has signed a partnership agreement with LegoChem Biosciences, a Korean biotech company pioneering the research and development of antibody-drug conjugate (ADC) programmes.
1 min
Biocon Biologics partners with Sandoz Australia for cancer biosimilars
Indian firm Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon, has announced a five-year partnership with Sandoz AG which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million) and biosimilar Bevacizumab (market value of AUD$45 million) in Australia.
1 min
Eris Lifesciences expands footprint in sterile injectables with acquisition of 51% stake in Swiss Parenterals
India-based Eris Lifesciences has announced the expansion of its sterile injectables footprint through the acquisition of 51 per cent equity stake in Swiss Parenterals for a consideration of Rs 637.5 crore.
1 min
NITI Aayog releases report for senior care reforms in India
NITI Aayog has released a position paper titled 'Senior Care Reforms in India: Reimagining the Senior Care Paradigm'.
1 min
Ministry of Health in New Zealand inks MoU with of Waikato to build medical school University
The Ministry of Health, government of New Zealand, and the University of Waikato have signed a Memorandum of Understanding (MoU) as a first step towards establishing a new medical school.
1 min
Australia establishes new task force to guide use of AI in public health system
New South Wales (NSW) Health in Australia has established a new taskforce to inform and guide the use of artificial intelligence (AI) in the public health system.
1 min
Breakthroughs in Rare Diseases Therapeutics
2024 rings positive for those suffering from some kind of rare disease. On January 16, 2024, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the US Food and Drug Administration has approved the use of Casgevy, a therapy that uses CRISPR gene-editing to treat the serious blood disorder, transfusion-dependent beta-thalassemia, marking the second major US regulatory approval for the emerging gene-editing technology. This approval is a testament to the breakthroughs in therapeutics for rare medical conditions.
5 mins
Japan approves first at-home migraine treatment in the form of Neurolief's neuromodulation device
US-based Neurolief has announced the approval of its neuromodulation device, Relivion, by the Japanese Ministry of Health, Labor and Welfare (MHLW).
1 min
New Zealand to make amendments to International Health Regulations
The Ministry of Health is inviting the views of New Zealanders on proposals to update a significant global health agreement.
1 min
Indian Immunologicals invests Rs 700 Cr in new vaccine manufacturing plant in India
Indian Immunologicals Limited (IIL) has started construction of its new greenfield veterinary vaccine facility to manufacture the Foot and Mouth Disease Vaccine (FMD-Vac) as well as Foot and Mouth Disease + Haemorrhagic Septicaemia Vaccine (FMD+HS-Vac) in Hyderabad’s Genome valley, India.
1 min
Korea's LegoChem Biosciences inks $1.7B pact with J&J for ADC development
South Korea's LegoChem Biosciences (LCB) has entered into a license agreement with Janssen Biotech, Inc. (Janssen), a Johnson & Johnson (J&J) company, to develop and commercialise LCB84, a Trop2-directed antibody-drug conjugate (ADC).
1 min
Zuellig Pharma & Substipharm Biologics expand access to Japanese Encephalitis vaccine across Asia
Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substipharm Biologics, to expand access of the IMOJEV Japanese encephalitis vaccine across nine markets in Asia, including Brunei, Cambodia, Hong Kong, Malaysia, Myanmar, Philippines, Singapore, Taiwan and Vietnam. Japanese Encephalitis (JE) is transmitted with mosquitoes and causes inflammation in the brain and is the leading cause of vaccine-preventable encephalitis in Asia.
1 min
Lunit AI solutions to power Samsung's X-ray devices for advanced chest screening
South Korea-based company Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced a three-year supply contract with Samsung Electronics (Samsung Healthcare).
1 min
Novartis acquires Chinese startup SanReno Therapeutics to enhance kidney diseases treatment
China-based startup SanReno Therapeutics, a clinical-stage company specialising in the discovery, development, and commercialisation of innovative therapies for kidney diseases, has announced its acquisition by Novartis, a global medicines company.
1 min
WHO grants Emergency Use Listing to Biological E's COVID-19 vaccine Corbevax
Biological E (BE), an India-based vaccines and pharmaceutical company, has announced that the World Health Organization (WHO) has granted an Emergency Use Listing (EUL) to their Corbevax vaccine, which is India's first indigenously developed COVID-19 vaccine that is based on protein sub-unit platform.
1 min
Novo Nordisk Foundation signs $25M partnership with CARB-X to fight drug-resistant infections
Denmark-headquartered Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections.
1 min
Qure.ai's Al-driven chest X-ray solution gets FDA clearance for enhanced lung nodule detection
Qure.ai, a health tech company that uses deep learning and Artificial Intelligence (AI) tools to make healthcare more accessible, has announced its 13th FDA clearance for its AI-enabled solutions.
1 min
Indian researchers link ageing of cells with ovarian cancer spread
Researchers at the Indian Institute of Science (IISc) in Bengaluru have found that ovarian cancer cells can spread more easily in tissues that are senescent or aged because these tissues secrete a unique extracellular matrix that attracts the spreading cancer.
1 min
Australia develops tool to identify dust lung disease risk
A new dust testing methodology developed by Australia-based University of Queensland researchers offers workers better protection from diseases such as black lung and silicosis.
1 min
Korea designs wrist rotation module to enhance usability and efficiency in prosthetic limbs
Robotic assistive devices play a crucial role in supporting the daily activities of individuals with congenital disabilities or those who have experienced unfortunate accidents.
1 min
Dr Kuldeep Singh Sachdeva to assume key leadership role at Molbio Diagnostics
India-based Molbio Diagnostics has announced the appointment of Dr Kuldeep Singh Sachdeva to its leadership team.
1 min
BioSpectrum Asia Magazine Description:
Publisher: MM Activ Sci-Tech Communication
Category: Business
Language: English
Frequency: Monthly
BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:
* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.
BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.
- Cancel Anytime [ No Commitments ]
- Digital Only